COVID-19 Impact on Global Injectable Nanomedicines Market Insights, Forecast to 2026
Injectable Nanomedicines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Injectable Nanomedicines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Injectable Nanomedicines market is segmented into
The Injectable Nanomedicines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Injectable Nanomedicines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Injectable Nanomedicines Market Share Analysis
Injectable Nanomedicines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Injectable Nanomedicines business, the date to enter into the Injectable Nanomedicines market, Injectable Nanomedicines product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Injectable Nanomedicines market is segmented into
- Liposomes
- Micelles
- Nanocrystals
- Polymeric Nanoparticles
- Other
- Cancer
- Central Nervous System Disease
- Cardiovascular Disease
- Infection Control
- Other
The Injectable Nanomedicines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Injectable Nanomedicines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Injectable Nanomedicines Market Share Analysis
Injectable Nanomedicines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Injectable Nanomedicines business, the date to enter into the Injectable Nanomedicines market, Injectable Nanomedicines product introduction, recent developments, etc.
The major vendors covered:
- Merck
- Lupin
- Pacira Pharmaceuticals
- Celgene Pharmaceutical
- Amgen
- Janssen Biotech
- Pfizer
- Hoffmann-La Roche
- Teva Pharmaceutical Industries
- Bausch & Lomb
1 STUDY COVERAGE
1.1 Injectable Nanomedicines Product Introduction
1.2 Market Segments
1.3 Key Injectable Nanomedicines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Injectable Nanomedicines Market Size Growth Rate by Type
1.4.2 Liposomes
1.4.3 Micelles
1.4.4 Nanocrystals
1.4.5 Polymeric Nanoparticles
1.4.6 Other
1.5 Market by Application
1.5.1 Global Injectable Nanomedicines Market Size Growth Rate by Application
1.5.2 Cancer
1.5.3 Central Nervous System Disease
1.5.4 Cardiovascular Disease
1.5.5 Infection Control
1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Injectable Nanomedicines Industry Impact
1.6.1 How the Covid-19 is Affecting the Injectable Nanomedicines Industry
1.6.1.1 Injectable Nanomedicines Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Injectable Nanomedicines Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Injectable Nanomedicines Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Injectable Nanomedicines Market Size Estimates and Forecasts
2.1.1 Global Injectable Nanomedicines Revenue 2015-2026
2.1.2 Global Injectable Nanomedicines Sales 2015-2026
2.2 Injectable Nanomedicines Market Size by Region: 2020 Versus 2026
2.2.1 Global Injectable Nanomedicines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Injectable Nanomedicines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL INJECTABLE NANOMEDICINES COMPETITOR LANDSCAPE BY PLAYERS
3.1 Injectable Nanomedicines Sales by Manufacturers
3.1.1 Injectable Nanomedicines Sales by Manufacturers (2015-2020)
3.1.2 Injectable Nanomedicines Sales Market Share by Manufacturers (2015-2020)
3.2 Injectable Nanomedicines Revenue by Manufacturers
3.2.1 Injectable Nanomedicines Revenue by Manufacturers (2015-2020)
3.2.2 Injectable Nanomedicines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Injectable Nanomedicines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Injectable Nanomedicines Revenue in 2019
3.2.5 Global Injectable Nanomedicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Injectable Nanomedicines Price by Manufacturers
3.4 Injectable Nanomedicines Manufacturing Base Distribution, Product Types
3.4.1 Injectable Nanomedicines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Injectable Nanomedicines Product Type
3.4.3 Date of International Manufacturers Enter into Injectable Nanomedicines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Injectable Nanomedicines Market Size by Type (2015-2020)
4.1.1 Global Injectable Nanomedicines Sales by Type (2015-2020)
4.1.2 Global Injectable Nanomedicines Revenue by Type (2015-2020)
4.1.3 Injectable Nanomedicines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Injectable Nanomedicines Market Size Forecast by Type (2021-2026)
4.2.1 Global Injectable Nanomedicines Sales Forecast by Type (2021-2026)
4.2.2 Global Injectable Nanomedicines Revenue Forecast by Type (2021-2026)
4.2.3 Injectable Nanomedicines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Injectable Nanomedicines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Injectable Nanomedicines Market Size by Application (2015-2020)
5.1.1 Global Injectable Nanomedicines Sales by Application (2015-2020)
5.1.2 Global Injectable Nanomedicines Revenue by Application (2015-2020)
5.1.3 Injectable Nanomedicines Price by Application (2015-2020)
5.2 Injectable Nanomedicines Market Size Forecast by Application (2021-2026)
5.2.1 Global Injectable Nanomedicines Sales Forecast by Application (2021-2026)
5.2.2 Global Injectable Nanomedicines Revenue Forecast by Application (2021-2026)
5.2.3 Global Injectable Nanomedicines Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Injectable Nanomedicines by Country
6.1.1 North America Injectable Nanomedicines Sales by Country
6.1.2 North America Injectable Nanomedicines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Injectable Nanomedicines Market Facts & Figures by Type
6.3 North America Injectable Nanomedicines Market Facts & Figures by Application
7 EUROPE
7.1 Europe Injectable Nanomedicines by Country
7.1.1 Europe Injectable Nanomedicines Sales by Country
7.1.2 Europe Injectable Nanomedicines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Injectable Nanomedicines Market Facts & Figures by Type
7.3 Europe Injectable Nanomedicines Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Injectable Nanomedicines by Region
8.1.1 Asia Pacific Injectable Nanomedicines Sales by Region
8.1.2 Asia Pacific Injectable Nanomedicines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Injectable Nanomedicines Market Facts & Figures by Type
8.3 Asia Pacific Injectable Nanomedicines Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Injectable Nanomedicines by Country
9.1.1 Latin America Injectable Nanomedicines Sales by Country
9.1.2 Latin America Injectable Nanomedicines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Injectable Nanomedicines Market Facts & Figures by Type
9.3 Central & South America Injectable Nanomedicines Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Injectable Nanomedicines by Country
10.1.1 Middle East and Africa Injectable Nanomedicines Sales by Country
10.1.2 Middle East and Africa Injectable Nanomedicines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Injectable Nanomedicines Market Facts & Figures by Type
10.3 Middle East and Africa Injectable Nanomedicines Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description, Business Overview and Total Revenue
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Injectable Nanomedicines Products Offered
11.1.5 Merck Recent Development
11.2 Lupin
11.2.1 Lupin Corporation Information
11.2.2 Lupin Description, Business Overview and Total Revenue
11.2.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Lupin Injectable Nanomedicines Products Offered
11.2.5 Lupin Recent Development
11.3 Pacira Pharmaceuticals
11.3.1 Pacira Pharmaceuticals Corporation Information
11.3.2 Pacira Pharmaceuticals Description, Business Overview and Total Revenue
11.3.3 Pacira Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pacira Pharmaceuticals Injectable Nanomedicines Products Offered
11.3.5 Pacira Pharmaceuticals Recent Development
11.4 Celgene Pharmaceutical
11.4.1 Celgene Pharmaceutical Corporation Information
11.4.2 Celgene Pharmaceutical Description, Business Overview and Total Revenue
11.4.3 Celgene Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Celgene Pharmaceutical Injectable Nanomedicines Products Offered
11.4.5 Celgene Pharmaceutical Recent Development
11.5 Amgen
11.5.1 Amgen Corporation Information
11.5.2 Amgen Description, Business Overview and Total Revenue
11.5.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Amgen Injectable Nanomedicines Products Offered
11.5.5 Amgen Recent Development
11.6 Janssen Biotech
11.6.1 Janssen Biotech Corporation Information
11.6.2 Janssen Biotech Description, Business Overview and Total Revenue
11.6.3 Janssen Biotech Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Janssen Biotech Injectable Nanomedicines Products Offered
11.6.5 Janssen Biotech Recent Development
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Description, Business Overview and Total Revenue
11.7.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Pfizer Injectable Nanomedicines Products Offered
11.7.5 Pfizer Recent Development
11.8 Hoffmann-La Roche
11.8.1 Hoffmann-La Roche Corporation Information
11.8.2 Hoffmann-La Roche Description, Business Overview and Total Revenue
11.8.3 Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Hoffmann-La Roche Injectable Nanomedicines Products Offered
11.8.5 Hoffmann-La Roche Recent Development
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Corporation Information
11.9.2 Teva Pharmaceutical Industries Description, Business Overview and Total Revenue
11.9.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Teva Pharmaceutical Industries Injectable Nanomedicines Products Offered
11.9.5 Teva Pharmaceutical Industries Recent Development
11.10 Bausch & Lomb
11.10.1 Bausch & Lomb Corporation Information
11.10.2 Bausch & Lomb Description, Business Overview and Total Revenue
11.10.3 Bausch & Lomb Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Bausch & Lomb Injectable Nanomedicines Products Offered
11.10.5 Bausch & Lomb Recent Development
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description, Business Overview and Total Revenue
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Injectable Nanomedicines Products Offered
11.1.5 Merck Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Injectable Nanomedicines Market Estimates and Projections by Region
12.1.1 Global Injectable Nanomedicines Sales Forecast by Regions 2021-2026
12.1.2 Global Injectable Nanomedicines Revenue Forecast by Regions 2021-2026
12.2 North America Injectable Nanomedicines Market Size Forecast (2021-2026)
12.2.1 North America: Injectable Nanomedicines Sales Forecast (2021-2026)
12.2.2 North America: Injectable Nanomedicines Revenue Forecast (2021-2026)
12.2.3 North America: Injectable Nanomedicines Market Size Forecast by Country (2021-2026)
12.3 Europe Injectable Nanomedicines Market Size Forecast (2021-2026)
12.3.1 Europe: Injectable Nanomedicines Sales Forecast (2021-2026)
12.3.2 Europe: Injectable Nanomedicines Revenue Forecast (2021-2026)
12.3.3 Europe: Injectable Nanomedicines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Injectable Nanomedicines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Injectable Nanomedicines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Injectable Nanomedicines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Injectable Nanomedicines Market Size Forecast by Region (2021-2026)
12.5 Latin America Injectable Nanomedicines Market Size Forecast (2021-2026)
12.5.1 Latin America: Injectable Nanomedicines Sales Forecast (2021-2026)
12.5.2 Latin America: Injectable Nanomedicines Revenue Forecast (2021-2026)
12.5.3 Latin America: Injectable Nanomedicines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Injectable Nanomedicines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Injectable Nanomedicines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Injectable Nanomedicines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Injectable Nanomedicines Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Injectable Nanomedicines Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Injectable Nanomedicines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Injectable Nanomedicines Product Introduction
1.2 Market Segments
1.3 Key Injectable Nanomedicines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Injectable Nanomedicines Market Size Growth Rate by Type
1.4.2 Liposomes
1.4.3 Micelles
1.4.4 Nanocrystals
1.4.5 Polymeric Nanoparticles
1.4.6 Other
1.5 Market by Application
1.5.1 Global Injectable Nanomedicines Market Size Growth Rate by Application
1.5.2 Cancer
1.5.3 Central Nervous System Disease
1.5.4 Cardiovascular Disease
1.5.5 Infection Control
1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Injectable Nanomedicines Industry Impact
1.6.1 How the Covid-19 is Affecting the Injectable Nanomedicines Industry
1.6.1.1 Injectable Nanomedicines Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Injectable Nanomedicines Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Injectable Nanomedicines Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Injectable Nanomedicines Market Size Estimates and Forecasts
2.1.1 Global Injectable Nanomedicines Revenue 2015-2026
2.1.2 Global Injectable Nanomedicines Sales 2015-2026
2.2 Injectable Nanomedicines Market Size by Region: 2020 Versus 2026
2.2.1 Global Injectable Nanomedicines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Injectable Nanomedicines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL INJECTABLE NANOMEDICINES COMPETITOR LANDSCAPE BY PLAYERS
3.1 Injectable Nanomedicines Sales by Manufacturers
3.1.1 Injectable Nanomedicines Sales by Manufacturers (2015-2020)
3.1.2 Injectable Nanomedicines Sales Market Share by Manufacturers (2015-2020)
3.2 Injectable Nanomedicines Revenue by Manufacturers
3.2.1 Injectable Nanomedicines Revenue by Manufacturers (2015-2020)
3.2.2 Injectable Nanomedicines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Injectable Nanomedicines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Injectable Nanomedicines Revenue in 2019
3.2.5 Global Injectable Nanomedicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Injectable Nanomedicines Price by Manufacturers
3.4 Injectable Nanomedicines Manufacturing Base Distribution, Product Types
3.4.1 Injectable Nanomedicines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Injectable Nanomedicines Product Type
3.4.3 Date of International Manufacturers Enter into Injectable Nanomedicines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Injectable Nanomedicines Market Size by Type (2015-2020)
4.1.1 Global Injectable Nanomedicines Sales by Type (2015-2020)
4.1.2 Global Injectable Nanomedicines Revenue by Type (2015-2020)
4.1.3 Injectable Nanomedicines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Injectable Nanomedicines Market Size Forecast by Type (2021-2026)
4.2.1 Global Injectable Nanomedicines Sales Forecast by Type (2021-2026)
4.2.2 Global Injectable Nanomedicines Revenue Forecast by Type (2021-2026)
4.2.3 Injectable Nanomedicines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Injectable Nanomedicines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Injectable Nanomedicines Market Size by Application (2015-2020)
5.1.1 Global Injectable Nanomedicines Sales by Application (2015-2020)
5.1.2 Global Injectable Nanomedicines Revenue by Application (2015-2020)
5.1.3 Injectable Nanomedicines Price by Application (2015-2020)
5.2 Injectable Nanomedicines Market Size Forecast by Application (2021-2026)
5.2.1 Global Injectable Nanomedicines Sales Forecast by Application (2021-2026)
5.2.2 Global Injectable Nanomedicines Revenue Forecast by Application (2021-2026)
5.2.3 Global Injectable Nanomedicines Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Injectable Nanomedicines by Country
6.1.1 North America Injectable Nanomedicines Sales by Country
6.1.2 North America Injectable Nanomedicines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Injectable Nanomedicines Market Facts & Figures by Type
6.3 North America Injectable Nanomedicines Market Facts & Figures by Application
7 EUROPE
7.1 Europe Injectable Nanomedicines by Country
7.1.1 Europe Injectable Nanomedicines Sales by Country
7.1.2 Europe Injectable Nanomedicines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Injectable Nanomedicines Market Facts & Figures by Type
7.3 Europe Injectable Nanomedicines Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Injectable Nanomedicines by Region
8.1.1 Asia Pacific Injectable Nanomedicines Sales by Region
8.1.2 Asia Pacific Injectable Nanomedicines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Injectable Nanomedicines Market Facts & Figures by Type
8.3 Asia Pacific Injectable Nanomedicines Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Injectable Nanomedicines by Country
9.1.1 Latin America Injectable Nanomedicines Sales by Country
9.1.2 Latin America Injectable Nanomedicines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Injectable Nanomedicines Market Facts & Figures by Type
9.3 Central & South America Injectable Nanomedicines Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Injectable Nanomedicines by Country
10.1.1 Middle East and Africa Injectable Nanomedicines Sales by Country
10.1.2 Middle East and Africa Injectable Nanomedicines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Injectable Nanomedicines Market Facts & Figures by Type
10.3 Middle East and Africa Injectable Nanomedicines Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description, Business Overview and Total Revenue
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Injectable Nanomedicines Products Offered
11.1.5 Merck Recent Development
11.2 Lupin
11.2.1 Lupin Corporation Information
11.2.2 Lupin Description, Business Overview and Total Revenue
11.2.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Lupin Injectable Nanomedicines Products Offered
11.2.5 Lupin Recent Development
11.3 Pacira Pharmaceuticals
11.3.1 Pacira Pharmaceuticals Corporation Information
11.3.2 Pacira Pharmaceuticals Description, Business Overview and Total Revenue
11.3.3 Pacira Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pacira Pharmaceuticals Injectable Nanomedicines Products Offered
11.3.5 Pacira Pharmaceuticals Recent Development
11.4 Celgene Pharmaceutical
11.4.1 Celgene Pharmaceutical Corporation Information
11.4.2 Celgene Pharmaceutical Description, Business Overview and Total Revenue
11.4.3 Celgene Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Celgene Pharmaceutical Injectable Nanomedicines Products Offered
11.4.5 Celgene Pharmaceutical Recent Development
11.5 Amgen
11.5.1 Amgen Corporation Information
11.5.2 Amgen Description, Business Overview and Total Revenue
11.5.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Amgen Injectable Nanomedicines Products Offered
11.5.5 Amgen Recent Development
11.6 Janssen Biotech
11.6.1 Janssen Biotech Corporation Information
11.6.2 Janssen Biotech Description, Business Overview and Total Revenue
11.6.3 Janssen Biotech Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Janssen Biotech Injectable Nanomedicines Products Offered
11.6.5 Janssen Biotech Recent Development
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Description, Business Overview and Total Revenue
11.7.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Pfizer Injectable Nanomedicines Products Offered
11.7.5 Pfizer Recent Development
11.8 Hoffmann-La Roche
11.8.1 Hoffmann-La Roche Corporation Information
11.8.2 Hoffmann-La Roche Description, Business Overview and Total Revenue
11.8.3 Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Hoffmann-La Roche Injectable Nanomedicines Products Offered
11.8.5 Hoffmann-La Roche Recent Development
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Corporation Information
11.9.2 Teva Pharmaceutical Industries Description, Business Overview and Total Revenue
11.9.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Teva Pharmaceutical Industries Injectable Nanomedicines Products Offered
11.9.5 Teva Pharmaceutical Industries Recent Development
11.10 Bausch & Lomb
11.10.1 Bausch & Lomb Corporation Information
11.10.2 Bausch & Lomb Description, Business Overview and Total Revenue
11.10.3 Bausch & Lomb Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Bausch & Lomb Injectable Nanomedicines Products Offered
11.10.5 Bausch & Lomb Recent Development
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description, Business Overview and Total Revenue
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Injectable Nanomedicines Products Offered
11.1.5 Merck Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Injectable Nanomedicines Market Estimates and Projections by Region
12.1.1 Global Injectable Nanomedicines Sales Forecast by Regions 2021-2026
12.1.2 Global Injectable Nanomedicines Revenue Forecast by Regions 2021-2026
12.2 North America Injectable Nanomedicines Market Size Forecast (2021-2026)
12.2.1 North America: Injectable Nanomedicines Sales Forecast (2021-2026)
12.2.2 North America: Injectable Nanomedicines Revenue Forecast (2021-2026)
12.2.3 North America: Injectable Nanomedicines Market Size Forecast by Country (2021-2026)
12.3 Europe Injectable Nanomedicines Market Size Forecast (2021-2026)
12.3.1 Europe: Injectable Nanomedicines Sales Forecast (2021-2026)
12.3.2 Europe: Injectable Nanomedicines Revenue Forecast (2021-2026)
12.3.3 Europe: Injectable Nanomedicines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Injectable Nanomedicines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Injectable Nanomedicines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Injectable Nanomedicines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Injectable Nanomedicines Market Size Forecast by Region (2021-2026)
12.5 Latin America Injectable Nanomedicines Market Size Forecast (2021-2026)
12.5.1 Latin America: Injectable Nanomedicines Sales Forecast (2021-2026)
12.5.2 Latin America: Injectable Nanomedicines Revenue Forecast (2021-2026)
12.5.3 Latin America: Injectable Nanomedicines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Injectable Nanomedicines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Injectable Nanomedicines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Injectable Nanomedicines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Injectable Nanomedicines Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Injectable Nanomedicines Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Injectable Nanomedicines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Injectable Nanomedicines Market Segments
Table 2. Ranking of Global Top Injectable Nanomedicines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Injectable Nanomedicines Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Liposomes
Table 5. Major Manufacturers of Micelles
Table 6. Major Manufacturers of Nanocrystals
Table 7. Major Manufacturers of Polymeric Nanoparticles
Table 8. Major Manufacturers of Other
Table 9. COVID-19 Impact Global Market: (Four Injectable Nanomedicines Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Injectable Nanomedicines Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Injectable Nanomedicines Players to Combat Covid-19 Impact
Table 14. Global Injectable Nanomedicines Market Size Growth Rate by Application 2020-2026 (MT)
Table 15. Global Injectable Nanomedicines Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 16. Global Injectable Nanomedicines Sales by Regions 2015-2020 (MT)
Table 17. Global Injectable Nanomedicines Sales Market Share by Regions (2015-2020)
Table 18. Global Injectable Nanomedicines Revenue by Regions 2015-2020 (US$ Million)
Table 19. Global Injectable Nanomedicines Sales by Manufacturers (2015-2020) (MT)
Table 20. Global Injectable Nanomedicines Sales Share by Manufacturers (2015-2020)
Table 21. Global Injectable Nanomedicines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 22. Global Injectable Nanomedicines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Nanomedicines as of 2019)
Table 23. Injectable Nanomedicines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 24. Injectable Nanomedicines Revenue Share by Manufacturers (2015-2020)
Table 25. Key Manufacturers Injectable Nanomedicines Price (2015-2020) (USD/Kg)
Table 26. Injectable Nanomedicines Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Injectable Nanomedicines Product Type
Table 28. Date of International Manufacturers Enter into Injectable Nanomedicines Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Injectable Nanomedicines Sales by Type (2015-2020) (MT)
Table 31. Global Injectable Nanomedicines Sales Share by Type (2015-2020)
Table 32. Global Injectable Nanomedicines Revenue by Type (2015-2020) (US$ Million)
Table 33. Global Injectable Nanomedicines Revenue Share by Type (2015-2020)
Table 34. Injectable Nanomedicines Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 35. Global Injectable Nanomedicines Sales by Application (2015-2020) (MT)
Table 36. Global Injectable Nanomedicines Sales Share by Application (2015-2020)
Table 37. North America Injectable Nanomedicines Sales by Country (2015-2020) (MT)
Table 38. North America Injectable Nanomedicines Sales Market Share by Country (2015-2020)
Table 39. North America Injectable Nanomedicines Revenue by Country (2015-2020) (US$ Million)
Table 40. North America Injectable Nanomedicines Revenue Market Share by Country (2015-2020)
Table 41. North America Injectable Nanomedicines Sales by Type (2015-2020) (MT)
Table 42. North America Injectable Nanomedicines Sales Market Share by Type (2015-2020)
Table 43. North America Injectable Nanomedicines Sales by Application (2015-2020) (MT)
Table 44. North America Injectable Nanomedicines Sales Market Share by Application (2015-2020)
Table 45. Europe Injectable Nanomedicines Sales by Country (2015-2020) (MT)
Table 46. Europe Injectable Nanomedicines Sales Market Share by Country (2015-2020)
Table 47. Europe Injectable Nanomedicines Revenue by Country (2015-2020) (US$ Million)
Table 48. Europe Injectable Nanomedicines Revenue Market Share by Country (2015-2020)
Table 49. Europe Injectable Nanomedicines Sales by Type (2015-2020) (MT)
Table 50. Europe Injectable Nanomedicines Sales Market Share by Type (2015-2020)
Table 51. Europe Injectable Nanomedicines Sales by Application (2015-2020) (MT)
Table 52. Europe Injectable Nanomedicines Sales Market Share by Application (2015-2020)
Table 53. Asia Pacific Injectable Nanomedicines Sales by Region (2015-2020) (MT)
Table 54. Asia Pacific Injectable Nanomedicines Sales Market Share by Region (2015-2020)
Table 55. Asia Pacific Injectable Nanomedicines Revenue by Region (2015-2020) (US$ Million)
Table 56. Asia Pacific Injectable Nanomedicines Revenue Market Share by Region (2015-2020)
Table 57. Asia Pacific Injectable Nanomedicines Sales by Type (2015-2020) (MT)
Table 58. Asia Pacific Injectable Nanomedicines Sales Market Share by Type (2015-2020)
Table 59. Asia Pacific Injectable Nanomedicines Sales by Application (2015-2020) (MT)
Table 60. Asia Pacific Injectable Nanomedicines Sales Market Share by Application (2015-2020)
Table 61. Latin America Injectable Nanomedicines Sales by Country (2015-2020) (MT)
Table 62. Latin America Injectable Nanomedicines Sales Market Share by Country (2015-2020)
Table 63. Latin Americaa Injectable Nanomedicines Revenue by Country (2015-2020) (US$ Million)
Table 64. Latin America Injectable Nanomedicines Revenue Market Share by Country (2015-2020)
Table 65. Latin America Injectable Nanomedicines Sales by Type (2015-2020) (MT)
Table 66. Latin America Injectable Nanomedicines Sales Market Share by Type (2015-2020)
Table 67. Latin America Injectable Nanomedicines Sales by Application (2015-2020) (MT)
Table 68. Latin America Injectable Nanomedicines Sales Market Share by Application (2015-2020)
Table 69. Middle East and Africa Injectable Nanomedicines Sales by Country (2015-2020) (MT)
Table 70. Middle East and Africa Injectable Nanomedicines Sales Market Share by Country (2015-2020)
Table 71. Middle East and Africa Injectable Nanomedicines Revenue by Country (2015-2020) (US$ Million)
Table 72. Middle East and Africa Injectable Nanomedicines Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Injectable Nanomedicines Sales by Type (2015-2020) (MT)
Table 74. Middle East and Africa Injectable Nanomedicines Sales Market Share by Type (2015-2020)
Table 75. Middle East and Africa Injectable Nanomedicines Sales by Application (2015-2020) (MT)
Table 76. Middle East and Africa Injectable Nanomedicines Sales Market Share by Application (2015-2020)
Table 77. Merck Corporation Information
Table 78. Merck Description and Major Businesses
Table 79. Merck Injectable Nanomedicines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 80. Merck Product
Table 81. Merck Recent Development
Table 82. Lupin Corporation Information
Table 83. Lupin Description and Major Businesses
Table 84. Lupin Injectable Nanomedicines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 85. Lupin Product
Table 86. Lupin Recent Development
Table 87. Pacira Pharmaceuticals Corporation Information
Table 88. Pacira Pharmaceuticals Description and Major Businesses
Table 89. Pacira Pharmaceuticals Injectable Nanomedicines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 90. Pacira Pharmaceuticals Product
Table 91. Pacira Pharmaceuticals Recent Development
Table 92. Celgene Pharmaceutical Corporation Information
Table 93. Celgene Pharmaceutical Description and Major Businesses
Table 94. Celgene Pharmaceutical Injectable Nanomedicines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 95. Celgene Pharmaceutical Product
Table 96. Celgene Pharmaceutical Recent Development
Table 97. Amgen Corporation Information
Table 98. Amgen Description and Major Businesses
Table 99. Amgen Injectable Nanomedicines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 100. Amgen Product
Table 101. Amgen Recent Development
Table 102. Janssen Biotech Corporation Information
Table 103. Janssen Biotech Description and Major Businesses
Table 104. Janssen Biotech Injectable Nanomedicines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 105. Janssen Biotech Product
Table 106. Janssen Biotech Recent Development
Table 107. Pfizer Corporation Information
Table 108. Pfizer Description and Major Businesses
Table 109. Pfizer Injectable Nanomedicines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 110. Pfizer Product
Table 111. Pfizer Recent Development
Table 112. Hoffmann-La Roche Corporation Information
Table 113. Hoffmann-La Roche Description and Major Businesses
Table 114. Hoffmann-La Roche Injectable Nanomedicines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 115. Hoffmann-La Roche Product
Table 116. Hoffmann-La Roche Recent Development
Table 117. Teva Pharmaceutical Industries Corporation Information
Table 118. Teva Pharmaceutical Industries Description and Major Businesses
Table 119. Teva Pharmaceutical Industries Injectable Nanomedicines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 120. Teva Pharmaceutical Industries Product
Table 121. Teva Pharmaceutical Industries Recent Development
Table 122. Bausch & Lomb Corporation Information
Table 123. Bausch & Lomb Description and Major Businesses
Table 124. Bausch & Lomb Injectable Nanomedicines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 125. Bausch & Lomb Product
Table 126. Bausch & Lomb Recent Development
Table 127. Global Injectable Nanomedicines Sales Forecast by Regions (2021-2026) (MT)
Table 128. Global Injectable Nanomedicines Sales Market Share Forecast by Regions (2021-2026)
Table 129. Global Injectable Nanomedicines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 130. Global Injectable Nanomedicines Revenue Market Share Forecast by Regions (2021-2026)
Table 131. North America: Injectable Nanomedicines Sales Forecast by Country (2021-2026) (MT)
Table 132. North America: Injectable Nanomedicines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Europe: Injectable Nanomedicines Sales Forecast by Country (2021-2026) (MT)
Table 134. Europe: Injectable Nanomedicines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Asia Pacific: Injectable Nanomedicines Sales Forecast by Region (2021-2026) (MT)
Table 136. Asia Pacific: Injectable Nanomedicines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 137. Latin America: Injectable Nanomedicines Sales Forecast by Country (2021-2026) (MT)
Table 138. Latin America: Injectable Nanomedicines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Middle East and Africa: Injectable Nanomedicines Sales Forecast by Country (2021-2026) (MT)
Table 140. Middle East and Africa: Injectable Nanomedicines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 142. Key Challenges
Table 143. Market Risks
Table 144. Main Points Interviewed from Key Injectable Nanomedicines Players
Table 145. Injectable Nanomedicines Customers List
Table 146. Injectable Nanomedicines Distributors List
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 1. Injectable Nanomedicines Market Segments
Table 2. Ranking of Global Top Injectable Nanomedicines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Injectable Nanomedicines Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Liposomes
Table 5. Major Manufacturers of Micelles
Table 6. Major Manufacturers of Nanocrystals
Table 7. Major Manufacturers of Polymeric Nanoparticles
Table 8. Major Manufacturers of Other
Table 9. COVID-19 Impact Global Market: (Four Injectable Nanomedicines Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Injectable Nanomedicines Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Injectable Nanomedicines Players to Combat Covid-19 Impact
Table 14. Global Injectable Nanomedicines Market Size Growth Rate by Application 2020-2026 (MT)
Table 15. Global Injectable Nanomedicines Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 16. Global Injectable Nanomedicines Sales by Regions 2015-2020 (MT)
Table 17. Global Injectable Nanomedicines Sales Market Share by Regions (2015-2020)
Table 18. Global Injectable Nanomedicines Revenue by Regions 2015-2020 (US$ Million)
Table 19. Global Injectable Nanomedicines Sales by Manufacturers (2015-2020) (MT)
Table 20. Global Injectable Nanomedicines Sales Share by Manufacturers (2015-2020)
Table 21. Global Injectable Nanomedicines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 22. Global Injectable Nanomedicines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Nanomedicines as of 2019)
Table 23. Injectable Nanomedicines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 24. Injectable Nanomedicines Revenue Share by Manufacturers (2015-2020)
Table 25. Key Manufacturers Injectable Nanomedicines Price (2015-2020) (USD/Kg)
Table 26. Injectable Nanomedicines Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Injectable Nanomedicines Product Type
Table 28. Date of International Manufacturers Enter into Injectable Nanomedicines Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Injectable Nanomedicines Sales by Type (2015-2020) (MT)
Table 31. Global Injectable Nanomedicines Sales Share by Type (2015-2020)
Table 32. Global Injectable Nanomedicines Revenue by Type (2015-2020) (US$ Million)
Table 33. Global Injectable Nanomedicines Revenue Share by Type (2015-2020)
Table 34. Injectable Nanomedicines Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 35. Global Injectable Nanomedicines Sales by Application (2015-2020) (MT)
Table 36. Global Injectable Nanomedicines Sales Share by Application (2015-2020)
Table 37. North America Injectable Nanomedicines Sales by Country (2015-2020) (MT)
Table 38. North America Injectable Nanomedicines Sales Market Share by Country (2015-2020)
Table 39. North America Injectable Nanomedicines Revenue by Country (2015-2020) (US$ Million)
Table 40. North America Injectable Nanomedicines Revenue Market Share by Country (2015-2020)
Table 41. North America Injectable Nanomedicines Sales by Type (2015-2020) (MT)
Table 42. North America Injectable Nanomedicines Sales Market Share by Type (2015-2020)
Table 43. North America Injectable Nanomedicines Sales by Application (2015-2020) (MT)
Table 44. North America Injectable Nanomedicines Sales Market Share by Application (2015-2020)
Table 45. Europe Injectable Nanomedicines Sales by Country (2015-2020) (MT)
Table 46. Europe Injectable Nanomedicines Sales Market Share by Country (2015-2020)
Table 47. Europe Injectable Nanomedicines Revenue by Country (2015-2020) (US$ Million)
Table 48. Europe Injectable Nanomedicines Revenue Market Share by Country (2015-2020)
Table 49. Europe Injectable Nanomedicines Sales by Type (2015-2020) (MT)
Table 50. Europe Injectable Nanomedicines Sales Market Share by Type (2015-2020)
Table 51. Europe Injectable Nanomedicines Sales by Application (2015-2020) (MT)
Table 52. Europe Injectable Nanomedicines Sales Market Share by Application (2015-2020)
Table 53. Asia Pacific Injectable Nanomedicines Sales by Region (2015-2020) (MT)
Table 54. Asia Pacific Injectable Nanomedicines Sales Market Share by Region (2015-2020)
Table 55. Asia Pacific Injectable Nanomedicines Revenue by Region (2015-2020) (US$ Million)
Table 56. Asia Pacific Injectable Nanomedicines Revenue Market Share by Region (2015-2020)
Table 57. Asia Pacific Injectable Nanomedicines Sales by Type (2015-2020) (MT)
Table 58. Asia Pacific Injectable Nanomedicines Sales Market Share by Type (2015-2020)
Table 59. Asia Pacific Injectable Nanomedicines Sales by Application (2015-2020) (MT)
Table 60. Asia Pacific Injectable Nanomedicines Sales Market Share by Application (2015-2020)
Table 61. Latin America Injectable Nanomedicines Sales by Country (2015-2020) (MT)
Table 62. Latin America Injectable Nanomedicines Sales Market Share by Country (2015-2020)
Table 63. Latin Americaa Injectable Nanomedicines Revenue by Country (2015-2020) (US$ Million)
Table 64. Latin America Injectable Nanomedicines Revenue Market Share by Country (2015-2020)
Table 65. Latin America Injectable Nanomedicines Sales by Type (2015-2020) (MT)
Table 66. Latin America Injectable Nanomedicines Sales Market Share by Type (2015-2020)
Table 67. Latin America Injectable Nanomedicines Sales by Application (2015-2020) (MT)
Table 68. Latin America Injectable Nanomedicines Sales Market Share by Application (2015-2020)
Table 69. Middle East and Africa Injectable Nanomedicines Sales by Country (2015-2020) (MT)
Table 70. Middle East and Africa Injectable Nanomedicines Sales Market Share by Country (2015-2020)
Table 71. Middle East and Africa Injectable Nanomedicines Revenue by Country (2015-2020) (US$ Million)
Table 72. Middle East and Africa Injectable Nanomedicines Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Injectable Nanomedicines Sales by Type (2015-2020) (MT)
Table 74. Middle East and Africa Injectable Nanomedicines Sales Market Share by Type (2015-2020)
Table 75. Middle East and Africa Injectable Nanomedicines Sales by Application (2015-2020) (MT)
Table 76. Middle East and Africa Injectable Nanomedicines Sales Market Share by Application (2015-2020)
Table 77. Merck Corporation Information
Table 78. Merck Description and Major Businesses
Table 79. Merck Injectable Nanomedicines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 80. Merck Product
Table 81. Merck Recent Development
Table 82. Lupin Corporation Information
Table 83. Lupin Description and Major Businesses
Table 84. Lupin Injectable Nanomedicines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 85. Lupin Product
Table 86. Lupin Recent Development
Table 87. Pacira Pharmaceuticals Corporation Information
Table 88. Pacira Pharmaceuticals Description and Major Businesses
Table 89. Pacira Pharmaceuticals Injectable Nanomedicines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 90. Pacira Pharmaceuticals Product
Table 91. Pacira Pharmaceuticals Recent Development
Table 92. Celgene Pharmaceutical Corporation Information
Table 93. Celgene Pharmaceutical Description and Major Businesses
Table 94. Celgene Pharmaceutical Injectable Nanomedicines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 95. Celgene Pharmaceutical Product
Table 96. Celgene Pharmaceutical Recent Development
Table 97. Amgen Corporation Information
Table 98. Amgen Description and Major Businesses
Table 99. Amgen Injectable Nanomedicines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 100. Amgen Product
Table 101. Amgen Recent Development
Table 102. Janssen Biotech Corporation Information
Table 103. Janssen Biotech Description and Major Businesses
Table 104. Janssen Biotech Injectable Nanomedicines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 105. Janssen Biotech Product
Table 106. Janssen Biotech Recent Development
Table 107. Pfizer Corporation Information
Table 108. Pfizer Description and Major Businesses
Table 109. Pfizer Injectable Nanomedicines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 110. Pfizer Product
Table 111. Pfizer Recent Development
Table 112. Hoffmann-La Roche Corporation Information
Table 113. Hoffmann-La Roche Description and Major Businesses
Table 114. Hoffmann-La Roche Injectable Nanomedicines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 115. Hoffmann-La Roche Product
Table 116. Hoffmann-La Roche Recent Development
Table 117. Teva Pharmaceutical Industries Corporation Information
Table 118. Teva Pharmaceutical Industries Description and Major Businesses
Table 119. Teva Pharmaceutical Industries Injectable Nanomedicines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 120. Teva Pharmaceutical Industries Product
Table 121. Teva Pharmaceutical Industries Recent Development
Table 122. Bausch & Lomb Corporation Information
Table 123. Bausch & Lomb Description and Major Businesses
Table 124. Bausch & Lomb Injectable Nanomedicines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 125. Bausch & Lomb Product
Table 126. Bausch & Lomb Recent Development
Table 127. Global Injectable Nanomedicines Sales Forecast by Regions (2021-2026) (MT)
Table 128. Global Injectable Nanomedicines Sales Market Share Forecast by Regions (2021-2026)
Table 129. Global Injectable Nanomedicines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 130. Global Injectable Nanomedicines Revenue Market Share Forecast by Regions (2021-2026)
Table 131. North America: Injectable Nanomedicines Sales Forecast by Country (2021-2026) (MT)
Table 132. North America: Injectable Nanomedicines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Europe: Injectable Nanomedicines Sales Forecast by Country (2021-2026) (MT)
Table 134. Europe: Injectable Nanomedicines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Asia Pacific: Injectable Nanomedicines Sales Forecast by Region (2021-2026) (MT)
Table 136. Asia Pacific: Injectable Nanomedicines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 137. Latin America: Injectable Nanomedicines Sales Forecast by Country (2021-2026) (MT)
Table 138. Latin America: Injectable Nanomedicines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Middle East and Africa: Injectable Nanomedicines Sales Forecast by Country (2021-2026) (MT)
Table 140. Middle East and Africa: Injectable Nanomedicines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 142. Key Challenges
Table 143. Market Risks
Table 144. Main Points Interviewed from Key Injectable Nanomedicines Players
Table 145. Injectable Nanomedicines Customers List
Table 146. Injectable Nanomedicines Distributors List
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Injectable Nanomedicines Product Picture
Figure 2. Global Injectable Nanomedicines Sales Market Share by Type in 2020 & 2026
Figure 3. Liposomes Product Picture
Figure 4. Micelles Product Picture
Figure 5. Nanocrystals Product Picture
Figure 6. Polymeric Nanoparticles Product Picture
Figure 7. Other Product Picture
Figure 8. Global Injectable Nanomedicines Sales Market Share by Application in 2020 & 2026
Figure 9. Cancer
Figure 10. Central Nervous System Disease
Figure 11. Cardiovascular Disease
Figure 12. Infection Control
Figure 13. Other
Figure 14. Injectable Nanomedicines Report Years Considered
Figure 15. Global Injectable Nanomedicines Market Size 2015-2026 (US$ Million)
Figure 16. Global Injectable Nanomedicines Sales 2015-2026 (MT)
Figure 17. Global Injectable Nanomedicines Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Injectable Nanomedicines Sales Market Share by Region (2015-2020)
Figure 19. Global Injectable Nanomedicines Sales Market Share by Region in 2019
Figure 20. Global Injectable Nanomedicines Revenue Market Share by Region (2015-2020)
Figure 21. Global Injectable Nanomedicines Revenue Market Share by Region in 2019
Figure 22. Global Injectable Nanomedicines Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Injectable Nanomedicines Revenue in 2019
Figure 24. Injectable Nanomedicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Injectable Nanomedicines Sales Market Share by Type (2015-2020)
Figure 26. Global Injectable Nanomedicines Sales Market Share by Type in 2019
Figure 27. Global Injectable Nanomedicines Revenue Market Share by Type (2015-2020)
Figure 28. Global Injectable Nanomedicines Revenue Market Share by Type in 2019
Figure 29. Global Injectable Nanomedicines Market Share by Price Range (2015-2020)
Figure 30. Global Injectable Nanomedicines Sales Market Share by Application (2015-2020)
Figure 31. Global Injectable Nanomedicines Sales Market Share by Application in 2019
Figure 32. Global Injectable Nanomedicines Revenue Market Share by Application (2015-2020)
Figure 33. Global Injectable Nanomedicines Revenue Market Share by Application in 2019
Figure 34. North America Injectable Nanomedicines Sales Growth Rate 2015-2020 (MT)
Figure 35. North America Injectable Nanomedicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Injectable Nanomedicines Sales Market Share by Country in 2019
Figure 37. North America Injectable Nanomedicines Revenue Market Share by Country in 2019
Figure 38. U.S. Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 39. U.S. Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 41. Canada Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Injectable Nanomedicines Market Share by Type in 2019
Figure 43. North America Injectable Nanomedicines Market Share by Application in 2019
Figure 44. Europe Injectable Nanomedicines Sales Growth Rate 2015-2020 (MT)
Figure 45. Europe Injectable Nanomedicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Injectable Nanomedicines Sales Market Share by Country in 2019
Figure 47. Europe Injectable Nanomedicines Revenue Market Share by Country in 2019
Figure 48. Germany Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 49. Germany Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 51. France Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 53. U.K. Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 55. Italy Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 57. Russia Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Injectable Nanomedicines Market Share by Type in 2019
Figure 59. Europe Injectable Nanomedicines Market Share by Application in 2019
Figure 60. Asia Pacific Injectable Nanomedicines Sales Growth Rate 2015-2020 (MT)
Figure 61. Asia Pacific Injectable Nanomedicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Injectable Nanomedicines Sales Market Share by Region in 2019
Figure 63. Asia Pacific Injectable Nanomedicines Revenue Market Share by Region in 2019
Figure 64. China Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 65. China Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 67. Japan Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 69. South Korea Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 71. India Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 73. Australia Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 75. Taiwan Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 77. Indonesia Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 79. Thailand Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 81. Malaysia Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 83. Philippines Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 85. Vietnam Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Injectable Nanomedicines Market Share by Type in 2019
Figure 87. Asia Pacific Injectable Nanomedicines Market Share by Application in 2019
Figure 88. Latin America Injectable Nanomedicines Sales Growth Rate 2015-2020 (MT)
Figure 89. Latin America Injectable Nanomedicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Injectable Nanomedicines Sales Market Share by Country in 2019
Figure 91. Latin America Injectable Nanomedicines Revenue Market Share by Country in 2019
Figure 92. Mexico Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 93. Mexico Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 95. Brazil Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 97. Argentina Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Injectable Nanomedicines Market Share by Type in 2019
Figure 99. Latin America Injectable Nanomedicines Market Share by Application in 2019
Figure 100. Middle East and Africa Injectable Nanomedicines Sales Growth Rate 2015-2020 (MT)
Figure 101. Middle East and Africa Injectable Nanomedicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Injectable Nanomedicines Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Injectable Nanomedicines Revenue Market Share by Country in 2019
Figure 104. Turkey Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 105. Turkey Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 107. Saudi Arabia Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 109. U.A.E Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Injectable Nanomedicines Market Share by Type in 2019
Figure 111. Middle East and Africa Injectable Nanomedicines Market Share by Application in 2019
Figure 112. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Lupin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Pacira Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Celgene Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Janssen Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Bausch & Lomb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. North America Injectable Nanomedicines Sales Growth Rate Forecast (2021-2026) (MT)
Figure 123. North America Injectable Nanomedicines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Europe Injectable Nanomedicines Sales Growth Rate Forecast (2021-2026) (MT)
Figure 125. Europe Injectable Nanomedicines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Asia Pacific Injectable Nanomedicines Sales Growth Rate Forecast (2021-2026) (MT)
Figure 127. Asia Pacific Injectable Nanomedicines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Latin America Injectable Nanomedicines Sales Growth Rate Forecast (2021-2026) (MT)
Figure 129. Latin America Injectable Nanomedicines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Middle East and Africa Injectable Nanomedicines Sales Growth Rate Forecast (2021-2026) (MT)
Figure 131. Middle East and Africa Injectable Nanomedicines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 132. Porter's Five Forces Analysis
Figure 133. Channels of Distribution
Figure 134. Distributors Profiles
Figure 135. Bottom-up and Top-down Approaches for This Report
Figure 136. Data Triangulation
Figure 137. Key Executives Interviewed
Figure 1. Injectable Nanomedicines Product Picture
Figure 2. Global Injectable Nanomedicines Sales Market Share by Type in 2020 & 2026
Figure 3. Liposomes Product Picture
Figure 4. Micelles Product Picture
Figure 5. Nanocrystals Product Picture
Figure 6. Polymeric Nanoparticles Product Picture
Figure 7. Other Product Picture
Figure 8. Global Injectable Nanomedicines Sales Market Share by Application in 2020 & 2026
Figure 9. Cancer
Figure 10. Central Nervous System Disease
Figure 11. Cardiovascular Disease
Figure 12. Infection Control
Figure 13. Other
Figure 14. Injectable Nanomedicines Report Years Considered
Figure 15. Global Injectable Nanomedicines Market Size 2015-2026 (US$ Million)
Figure 16. Global Injectable Nanomedicines Sales 2015-2026 (MT)
Figure 17. Global Injectable Nanomedicines Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Injectable Nanomedicines Sales Market Share by Region (2015-2020)
Figure 19. Global Injectable Nanomedicines Sales Market Share by Region in 2019
Figure 20. Global Injectable Nanomedicines Revenue Market Share by Region (2015-2020)
Figure 21. Global Injectable Nanomedicines Revenue Market Share by Region in 2019
Figure 22. Global Injectable Nanomedicines Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Injectable Nanomedicines Revenue in 2019
Figure 24. Injectable Nanomedicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Injectable Nanomedicines Sales Market Share by Type (2015-2020)
Figure 26. Global Injectable Nanomedicines Sales Market Share by Type in 2019
Figure 27. Global Injectable Nanomedicines Revenue Market Share by Type (2015-2020)
Figure 28. Global Injectable Nanomedicines Revenue Market Share by Type in 2019
Figure 29. Global Injectable Nanomedicines Market Share by Price Range (2015-2020)
Figure 30. Global Injectable Nanomedicines Sales Market Share by Application (2015-2020)
Figure 31. Global Injectable Nanomedicines Sales Market Share by Application in 2019
Figure 32. Global Injectable Nanomedicines Revenue Market Share by Application (2015-2020)
Figure 33. Global Injectable Nanomedicines Revenue Market Share by Application in 2019
Figure 34. North America Injectable Nanomedicines Sales Growth Rate 2015-2020 (MT)
Figure 35. North America Injectable Nanomedicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Injectable Nanomedicines Sales Market Share by Country in 2019
Figure 37. North America Injectable Nanomedicines Revenue Market Share by Country in 2019
Figure 38. U.S. Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 39. U.S. Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 41. Canada Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Injectable Nanomedicines Market Share by Type in 2019
Figure 43. North America Injectable Nanomedicines Market Share by Application in 2019
Figure 44. Europe Injectable Nanomedicines Sales Growth Rate 2015-2020 (MT)
Figure 45. Europe Injectable Nanomedicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Injectable Nanomedicines Sales Market Share by Country in 2019
Figure 47. Europe Injectable Nanomedicines Revenue Market Share by Country in 2019
Figure 48. Germany Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 49. Germany Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 51. France Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 53. U.K. Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 55. Italy Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 57. Russia Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Injectable Nanomedicines Market Share by Type in 2019
Figure 59. Europe Injectable Nanomedicines Market Share by Application in 2019
Figure 60. Asia Pacific Injectable Nanomedicines Sales Growth Rate 2015-2020 (MT)
Figure 61. Asia Pacific Injectable Nanomedicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Injectable Nanomedicines Sales Market Share by Region in 2019
Figure 63. Asia Pacific Injectable Nanomedicines Revenue Market Share by Region in 2019
Figure 64. China Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 65. China Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 67. Japan Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 69. South Korea Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 71. India Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 73. Australia Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 75. Taiwan Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 77. Indonesia Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 79. Thailand Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 81. Malaysia Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 83. Philippines Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 85. Vietnam Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Injectable Nanomedicines Market Share by Type in 2019
Figure 87. Asia Pacific Injectable Nanomedicines Market Share by Application in 2019
Figure 88. Latin America Injectable Nanomedicines Sales Growth Rate 2015-2020 (MT)
Figure 89. Latin America Injectable Nanomedicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Injectable Nanomedicines Sales Market Share by Country in 2019
Figure 91. Latin America Injectable Nanomedicines Revenue Market Share by Country in 2019
Figure 92. Mexico Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 93. Mexico Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 95. Brazil Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 97. Argentina Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Injectable Nanomedicines Market Share by Type in 2019
Figure 99. Latin America Injectable Nanomedicines Market Share by Application in 2019
Figure 100. Middle East and Africa Injectable Nanomedicines Sales Growth Rate 2015-2020 (MT)
Figure 101. Middle East and Africa Injectable Nanomedicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Injectable Nanomedicines Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Injectable Nanomedicines Revenue Market Share by Country in 2019
Figure 104. Turkey Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 105. Turkey Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 107. Saudi Arabia Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Injectable Nanomedicines Sales Growth Rate (2015-2020) (MT)
Figure 109. U.A.E Injectable Nanomedicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Injectable Nanomedicines Market Share by Type in 2019
Figure 111. Middle East and Africa Injectable Nanomedicines Market Share by Application in 2019
Figure 112. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Lupin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Pacira Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Celgene Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Janssen Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Bausch & Lomb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. North America Injectable Nanomedicines Sales Growth Rate Forecast (2021-2026) (MT)
Figure 123. North America Injectable Nanomedicines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Europe Injectable Nanomedicines Sales Growth Rate Forecast (2021-2026) (MT)
Figure 125. Europe Injectable Nanomedicines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Asia Pacific Injectable Nanomedicines Sales Growth Rate Forecast (2021-2026) (MT)
Figure 127. Asia Pacific Injectable Nanomedicines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Latin America Injectable Nanomedicines Sales Growth Rate Forecast (2021-2026) (MT)
Figure 129. Latin America Injectable Nanomedicines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Middle East and Africa Injectable Nanomedicines Sales Growth Rate Forecast (2021-2026) (MT)
Figure 131. Middle East and Africa Injectable Nanomedicines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 132. Porter's Five Forces Analysis
Figure 133. Channels of Distribution
Figure 134. Distributors Profiles
Figure 135. Bottom-up and Top-down Approaches for This Report
Figure 136. Data Triangulation
Figure 137. Key Executives Interviewed
